Financial Results Summary

Standalone Results (Quarter Ended June 30, 2026)

  • Revenue from Operations: Rs 68.36 lakhs (Net Sales/Income from Operations) + Rs 19.70 lakhs (Other Income) = Total Revenue: Rs 88.06 lakhs
  • Total Expenses: Rs 241.19 lakhs
  • Purchase of Stock-in-Trade: Rs 54.99 lakhs
  • Employee benefits expenses: Rs 21.34 lakhs
  • Finance Cost: Rs 153.10 lakhs
  • Depreciation and amortisation expenses: Rs 0.39 lakhs
  • Other Expenditure: Rs 11.37 lakhs
  • Loss before tax: Rs (153.13) lakhs
  • Tax Expenses: Nil
  • Loss for the period: Rs (153.13) lakhs
  • Other Comprehensive Income/(Expenses): Rs (0.33) lakhs
  • Total Comprehensive Loss: Rs (153.46) lakhs
  • Equity Share Capital: Rs 1,332.06 lakhs (Face Value Rs 10 per share)
  • Basic EPS: Rs (1.01)
  • Diluted EPS: Rs (1.01)

Consolidated Results (Quarter Ended June 30, 2026)

  • Revenue from Operations: Rs 68.36 lakhs (Net Sales/Income from Operations) + Rs 19.70 lakhs (Other Income) = Total Revenue: Rs 88.06 lakhs
  • Total Expenses: Rs 242.43 lakhs
  • Loss before tax: Rs (154.37) lakhs
  • Loss for the period: Rs (154.37) lakhs
  • Other Comprehensive Income/(Expenses): Rs (0.33) lakhs
  • Total Comprehensive Loss: Rs (154.70) lakhs
  • Equity Share Capital: Rs 1,332.06 lakhs
  • Basic EPS: Rs (1.02)
  • Diluted EPS: Rs (1.02)

Comparative Financial Performance

Standalone Quarterly Comparison (June 2026 vs March 2026)

  • Total Revenue: Rs 88.06 lakhs (Jun-26) vs Rs 5.68 lakhs (Mar-26)
  • Loss before tax: Rs (153.13) lakhs (Jun-26) vs Rs (203.35) lakhs (Mar-26)

Year-over-Year Standalone Comparison (Jun-26 vs Jun-25)

  • Total Revenue: Rs 88.06 lakhs (Jun-26) vs Rs 17.12 lakhs (Jun-25)
  • Loss before tax: Rs (153.13) lakhs (Jun-26) vs Rs (173.03) lakhs (Jun-25)

Key Notes and Disclosures

Accounting Treatment Qualification

Auditors (Khandelwal & Mehta LLP) have expressed a modified opinion regarding the company's treatment of Rs 185.00 lakhs payment towards release of collateral securities as 'Other Financial Assets'. This treatment is not in accordance with generally accepted accounting principles. Consequently:

  • Retained Earnings and Current Assets are higher by Rs 185.00 lakhs as on June 30, 2026
  • Management intends to adjust this amount after collateral securities are released by all security holders

Segment Reporting

The Company/Group operates in only one geographical region and has only one business segment, hence segment-wise reporting as required by IND AS 108 is not applicable.

Employee Benefits

Provision for leave encashment and gratuity has been provided based on management's best estimate, with actuarial valuation to be done at year-end.

Deferred Tax Asset

No deferred tax asset has been recognized as the Company/Group does not expect taxable profits in the near future.

Warrant Conversion

During the quarter, 20,99,750 warrants were converted into equity shares as part of the preferential issue approved on February 18, 2025. These warrants were allotted at an issue price of Rs 10 per equity share (Rs 2.50 warrant subscription price + Rs 7.50 warrant exercise price).

Board Meeting Details

The Board meeting was held on August 7, 2026, commencing at 2:15 PM and concluding at 2:50 PM. The financial results were reviewed by the Audit Committee and approved by the Board of Directors pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015.

Auditor Review

The statutory auditors, Khandelwal & Mehta LLP, have carried out a limited review of the financial results and issued qualified conclusions due to the accounting treatment of the Rs 185 lakhs payment.